Dokument: Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line

Titel:Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line
URL für Lesezeichen:https://docserv.uni-duesseldorf.de/servlets/DocumentServlet?id=71967
URN (NBN):urn:nbn:de:hbz:061-20260121-112928-9
Kollektion:Publikationen
Sprache:Englisch
Dokumententyp:Wissenschaftliche Texte » Artikel, Aufsatz
Medientyp:Text
Autoren: Thimm, Chantelle [Autor]
Mack, Rosanne [Autor]
Adjei-Aruna, Osmond [Autor]
Wruck, Wasco [Autor]
Adjaye, James [Autor]
Kular, Dalvir [Autor]
Koziell, Ania [Autor]
Bramham, Kate [Autor]
Dateien:
[Dateien anzeigen]Adobe PDF
[Details]6,20 MB in einer Datei
[ZIP-Datei erzeugen]
Dateien vom 21.01.2026 / geändert 21.01.2026
Stichwörter:Nephrogenesis , Interferon-ã , Rejuvenation , Baricitinib , Fibrosis, Inflammation , Partial reprogramming , SIX2-positive renal progenitor cell line , APOL1-mediated kidney disease , JAK/STAT signaling pathway
Beschreibung:Background

CKD affects approximately 850 million people worldwide and is a leading cause of mortality. Podocytes, cells in the kidney are terminally differentiated and incapable of division in vivo making the establishment of primary cultures particularly challenging. The ability of cells to proliferate and avoid senescence is closely linked to telomere length. However, cellular senescence ensues when telomere length becomes critically shortened.
Methods

We present the successful rejuvenation of a human SIX2-positive renal progenitor cell line derived from the urine of a 30-year-old West African male (UM30-OSN). To achieve partial reprogramming, plasmids expressing the Yamanaka factors OCT4, SOX2, NANOG, c-Myc, and KLF4 were employed.
Results

UM30-OSN expresses the pluripotency-associated marker SSEA4, renal stem cell markers such as SIX2, CD133 and CD24, determined by immunofluorescence, FACS and qPCR. Expression analysis revealed downregulation of senescence markers p21 and p53 and upregulation of proliferation-associated genes PCNA, KI67 and TERT, confirming rejuvenation. Upon podocyte differentiation, UM30-OSN cells expressed podocyte-specific markers NPHS1, NPHS2, SYNPO and CD2AP. Comparative transcriptome analyses revealed a correlation co-efficiency (R2 = 0.88) with the immortal podocyte line AB 8/13. To highlight the value of UM30-OSN in modeling APOL1-mediated kidney disease with an APOL1 (G1/G0) genotype, we examined how Interferon-γ (IFN-γ) affects UM30-OSN–derived podocytes and assessed whether the JAK1/JAK2 inhibitor Baricitinib can counteract IFN-γ–induced cellular responses. IFN-γ stimulation resulting in increased phosphorylation of STAT1, activation of APOL1, upregulation of pro-inflammatory and fibrotic markers such as, IL-6, TGF-β, Vimentin, Fibronectin, and morphological changes indicative of cell stress. Pre-treatment with Baricitinib effectively inhibited STAT1 phosphorylation, reduced expression of pro-inflammatory and fibrosis-associated genes, and preserved podocyte morphology.
Conclusion

Given their robust proliferation capacity, UM30-OSN cells represent a valuable additional model for investigating kidney-associated diseases such the contribution of APOL1 high-risk variants to kidney injury and fibrosis.
Rechtliche Vermerke:Originalveröffentlichung:
Thimm, C., Mack, R., Aruna, O., Wruck, W., Kular, D., Koziell, A., Bramham, K., & Adjaye, J. (2025). Modelling APOL1-mediated kidney inflammation and fibrosis using a partially reprogrammed urine-derived SIX2-positive renal progenitor cell line. Stem Cell Research & Therapy, 16(1), Article 630. https://doi.org/10.1186/s13287-025-04710-x
Lizenz:Creative Commons Lizenzvertrag
Dieses Werk ist lizenziert unter einer Creative Commons Namensnennung 4.0 International Lizenz
Fachbereich / Einrichtung:Medizinische Fakultät
Dokument erstellt am:21.01.2026
Dateien geändert am:21.01.2026
english
Benutzer
Status: Gast
Aktionen